These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17227756)

  • 1. Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors.
    Santiago-Josefat B; Esselens C; Bech-Serra JJ; Arribas J
    J Biol Chem; 2007 Mar; 282(11):8325-31. PubMed ID: 17227756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis.
    Bech-Serra JJ; Santiago-Josefat B; Esselens C; Saftig P; Baselga J; Arribas J; Canals F
    Mol Cell Biol; 2006 Jul; 26(13):5086-95. PubMed ID: 16782893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
    Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
    Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
    Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
    Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
    Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
    Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.
    Sahin U; Blobel CP
    FEBS Lett; 2007 Jan; 581(1):41-4. PubMed ID: 17169360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin.
    Nakayama H; Fukuda S; Inoue H; Nishida-Fukuda H; Shirakata Y; Hashimoto K; Higashiyama S
    Mol Biol Cell; 2012 May; 23(10):1964-75. PubMed ID: 22438584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
    Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
    Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
    Lee DC; Sunnarborg SW; Hinkle CL; Myers TJ; Stevenson MY; Russell WE; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Chang A; Jackson LF
    Ann N Y Acad Sci; 2003 May; 995():22-38. PubMed ID: 12814936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion.
    Giricz O; Calvo V; Peterson EA; Abouzeid CM; Kenny PA
    Int J Cancer; 2013 Dec; 133(11):2587-95. PubMed ID: 23729230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.
    Merlos-Suárez A; Ruiz-Paz S; Baselga J; Arribas J
    J Biol Chem; 2001 Dec; 276(51):48510-7. PubMed ID: 11600492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
    Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
    Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone is essential for maintenance of Tace/Adam17 mRNA expression, but not EGF-like factor, in cumulus cells, which enhances the EGF receptor signaling pathway during in vitro maturation of porcine COCs.
    Yamashita Y; Kawashima I; Gunji Y; Hishinuma M; Shimada M
    J Reprod Dev; 2010 Jun; 56(3):315-23. PubMed ID: 20168049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain.
    Lorenzen I; Trad A; Grötzinger J
    Biochem Biophys Res Commun; 2011 Nov; 415(2):330-6. PubMed ID: 22033402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.
    Li R; Uttarwar L; Gao B; Charbonneau M; Shi Y; Chan JS; Dubois CM; Krepinsky JC
    J Biol Chem; 2015 Aug; 290(35):21603-14. PubMed ID: 26175156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
    Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
    Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
    Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.